Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by juanonaon Nov 08, 2007 12:23pm
276 Views
Post# 13776821

RE: I still stick with my earlier calculation

RE: I still stick with my earlier calculationfdfd, with all due respect you might want to revisit your assumptions: to go from EBITDA to net earnings you have to take into account not only taxes, but also depreciation & amortization. As Paradign pointed out in their Aug report, these latter are likely to be substantial (due to all the M&A activity) but not really relevant to a fair value. They instead use EBITDA and a multiple of 12. Alternately, one could use Rob McWhirter's estimate of .84 net earnings which DO allow for Depreciation & Amortization. In the end I tend to agree with your fair share price based on FY08 estimates to be in the high teens, but I get there a little differently. On a related note, does anyone know how many shares outstanding we will have when the dust settles? With the extra 100M financing, along with the over-allotments, I suspect we are a bit over 100M. Good luck to all, Max
Bullboard Posts